Pegasus Mercantile Inc.
Pegasus Mercantile Inc.
Indice CSE:
Devise:
Xtacy Therapeutics Corp is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The present focus of the company is in hemp and CBD-related, psilocybin and functional mushrooms, and health-care related industries.
Pegasus Mercantile Inc. (LOAN)
SEDAR Information
Information d'entreprise
Addresse
1100 - 1111 Melville St
Vancouver, BC V3E 3V6
CanadaTéléphone
6042836110Courriel
info@xtacytherapeutics.comURL
https://xtacytherapeutics.com/Date d’inscription à la cote
Jeudi, juillet 16, 2009
Agent de transfert
Computershare Investor Services Inc.Relations avec les investisseurs
604-245-5974Courriel
info@xtacytherapeutics.comVérificateur
SHIM & Associates LLPCapitalisation
Capitalisation:
58156971Réservé à l'émission:
3363890Company Officers
Meris Kott, Director, CEO
Lindsey Perry Jr., Director and CFO
Ashleigh Vogstad, Director
Communiqués de presse
01/11/2024
Xtacy Announce Name and Symbol Change
Bulletins
04/11/2024
2024-1105 – Changement de Nom et de Symbole - Xtacy Therapeutics Corp. (XTCY)
le 4 novembre/November 2024
Xtacy Therapeutics Corp. (XTCY) has announced a name and symbol change to Pegasus Mercantile Inc. (LOAN).
Shares will begin trading under the new name and symbol and with a new CUSIP number on November 5, 2024.
Disclosure documents are available at www.thecse.com.